Evidence map›Paper›PMID 41104011›Full record

ArticleFrontiers in toxicology2025

Hospital admissions for acute drug poisoning in adults and children: a 7-year retrospective analysis of hospital discharges at a tertiary center.

Daniel Wang, Lina Camacho-Arteaga, Rosario Muñoz Gallarín, Immaculada Danés, Antònia Agustí Escasany

Abstract read
In one paragraph

Article in Frontiers in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniel WangDepartment of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.
Lina Camacho-ArteagaDepartment of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.
Rosario Muñoz GallarínDepartment of Medical Documentation, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Immaculada DanésDepartment of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.
Antònia Agustí EscasanyDepartment of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Drug poisoning is a growing public health concern, affecting both adult and pediatric populations. The COVID-19 pandemic has further influenced the incidence and patterns of these episodes. This study describes the clinical and epidemiological characteristics of drug poisoning episodes in adult and pediatric patients treated at a tertiary hospital in Spain between 2018 and 2024. Materials and methods: This retrospective, observational, single-center study used data from the Spanish Minimum Basic Data Set of Hospital Discharges (CMBD-AH). All hospitalizations coded with a diagnosis of drug poisoning (ICD-10-ES: T36-T50) were included. Variables analyzed included demographics, type of admission, drug class involved, intentionality, length of stay, ICU admission and duration, and clinical outcomes. Results: A total of 2,989 episodes with at least one drug poisoning code were identified in 2,481 patients (85.7% adults; 14.3% pediatric). The median age was 55 years in adults and 14 years in pediatric patients. Females predominated in both groups. Self-poisoning was the most frequent intentionality (52.4% in adults; 54.7% in pediatric patients), while accidental poisonings were more common in pediatric patients under 12 and adults over 60. Benzodiazepines were the most frequently involved drug-class across all age groups; in pediatric self-poisoning, paracetamol was most commonly implicated. ICU admission was required in 9.6% of pediatric and 9.2% of adult episodes. Mortality was reported in 3.3% of adult and 0.5% of pediatric episodes. Additionally, 12.5% of patients experienced recurrent episodes. A significant post-COVID increase in poisoning episodes was observed (p < 0.001). Conclusion: Although drug poisoning represented only 1.7% of all hospital discharges, it posed a substantial burden due to its frequency, recurrence, and ICU requirements. The CMBD-AH is a valuable tool for characterizing drug-related hospitalizations across age groups. Strengthened toxicovigilance, targeted prevention strategies, and early mental health interventions are essential to reduce its impact on healthcare systems.

Indexed as

adult drug poisoningdrug-related side effects and adverse reactionshospital recordsoverdosepediatric drug poisoningpoisoningpublic health surveillanceself-injurious behavior

Identifiers

PMID41104011
PMCPMC12521231

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.